Doctors' Assessment of Patient Compliance and Mortality in Type 2 Diabetes
Author Information
Author(s): Rothenbacher Dietrich, Rüter Gernot, Brenner Hermann
Primary Institution: German Centre for Research on Ageing, Heidelberg, Germany
Hypothesis
Is the physician's assessment of patient compliance a valuable prognostic marker for all-cause mortality in patients with type 2 diabetes?
Conclusion
The physician's assessment of patient compliance is a valuable prognostic marker for mortality among patients with type 2 diabetes.
Supporting Evidence
- Patients assessed as 'very bad' in compliance had a significantly higher mortality rate.
- Mortality was higher in patients visited at home or in nursing homes compared to those presenting at the office.
- Female patients had lower odds of dying compared to male patients.
Takeaway
Doctors can tell how likely a patient with diabetes is to get very sick or die based on how well they think the patient is following their treatment.
Methodology
A prospective cohort study was conducted among 1014 patients with type 2 diabetes, assessing compliance through a 4-point Likert scale and following up for one year to determine mortality.
Potential Biases
Potential bias in physician assessments and self-reported patient data.
Limitations
The study did not measure specific components of compliance like treatment adherence or diet compliance.
Participant Demographics
Patients aged 40 and over, mean age 69 years, 45% male, with a mix of those presenting at offices and those in nursing homes.
Statistical Information
P-Value
0.01
Confidence Interval
95% CI 1.02–6.97
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website